SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Vanguard Health Systems, Inc. in Connection with the Sale of the Company to Tenet Healthcare Corporation
Levi & Korsinsky is investigating the Board of Directors of Vanguard Health Systems, Inc. (“Vanguard Health” or the “Company”) (NYSE: VHS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Tenet Healthcare Corporation (NYSE: THC).
Click here to learn more about the investigation http://zlk.9nl.com/vanguard-health-vhs/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Vanguard Health shareholders will receive $21.00 for each share of Vanguard Health stock they own. The transaction has a total approximate value of $4.3 billion including the assumption of $2.5 billion in debt. The investigation concerns whether the Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether Tenet Healthcare Corporation is underpaying for Vanguard Health, thus unlawfully harming Vanguard Health shareholders.
If you own common stock in Vanguard Health and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/vanguard-health-vhs/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.